Medical News

Filters close
Newswise: 1 in 3 parents worry that school traffic is a danger for kids
10-Aug-2022 9:50 AM EDT
1 in 3 parents worry that school traffic is a danger for kids
Michigan Medicine - University of Michigan

Nearly a third of parents worry about their child’s safety to and from school with more than a quarter believing it’s likely that a child will get hurt near the drop-off area.

Released: 12-Aug-2022 5:05 PM EDT
Using mathematical modelling to fight malaria
University of Melbourne

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

Released: 12-Aug-2022 3:50 PM EDT
Testosterone promotes 'cuddling,' not just aggression, animal study finds
Emory University

Testosterone can foster friendly, prosocial behavior in males, a new animal study finds. The Proceedings of the Royal Society B published the research on Mongolian gerbils conducted by neuroscientists at Emory University.

   
Released: 12-Aug-2022 3:45 PM EDT
Breakthrough in search for tinnitus cure
University of Auckland

After 20 years searching for a cure for tinnitus, researchers at the University of Auckland are excited by ‘encouraging results’ from a clinical trial of a mobile-phone-based therapy.

Released: 12-Aug-2022 3:05 PM EDT
COVID-19 mRNA vaccines are safe in pregnancy, large study confirms
Lancet

Canadian study found 7.3% of pregnant women experienced health events requiring time off work or school or needing medical attention, such as headaches, fatigue and a general feeling of being unwell, within a week after dose two of a COVID-19 mRNA vaccine, compared to 11.3% of vaccinated non-pregnant women.

Released: 12-Aug-2022 3:05 PM EDT
Early-Term Births Associated With Higher Rate of ADHD as Reported by Teachers
Rutgers University-New Brunswick

Among children born at term (37–41 weeks), those born before 39 weeks are more likely to experience symptoms associated with attention-deficit/hyperactivity disorder (ADHD), according to a study by Rutgers Robert Wood Johnson Medical School.

Released: 12-Aug-2022 3:05 PM EDT
Drs. Julie Louise Gerberding, Martine Rothblatt to join Mayo Clinic Board of Trustees
Mayo Clinic

Julie Louise Gerberding, M.D., former director of the Centers for Disease Control and Prevention (CDC), and Martine Rothblatt, Ph.D., chairperson and CEO of United Therapeutics Corp. (Nasdaq:UTHR), were elected by the Mayo Clinic Board of Trustees as public trustees at its quarterly meeting on Aug. 12. They will join the Board of Trustees effective Nov. 10.

Released: 12-Aug-2022 2:05 PM EDT
A new way to control pain after knee replacement surgery
Houston Methodist

Houston Methodist researchers present clinical evidence supporting the safety and efficacy of injecting pain medication directly into the tibia during knee replacement surgery for better postoperative pain management. The study revealed patients receiving a mixture of morphine and vancomycin injected into the shin bone have less pain post-surgery than those who received the infusion without morphine during surgery.

Released: 12-Aug-2022 2:05 PM EDT
Newly updated CDC guidelines do not invalidate the protection that COVID-19 vaccines offer
Newswise

The claim that the new CDC guidelines prove that the authorized vaccines for COVID-19 do not provide any protection is false.

Released: 12-Aug-2022 2:05 PM EDT
Research studies focus on optimizing joint replacement surgery outcomes
Beth Israel Lahey Health

Two studies are included: Total joint replacement outcomes in the unhoused and health literacy linked to shoulder arthroplasty outcomes

access_time Embargo lifts in 2 days
This news release is embargoed until 15-Aug-2022 9:00 AM EDT Released to reporters: 12-Aug-2022 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Aug-2022 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVID-19 Immunity Test Inventor: ‘It’s Not Just About Antibodies’
Released: 12-Aug-2022 2:05 PM EDT
COVID-19 Immunity Test Inventor: ‘It’s Not Just About Antibodies’
Cedars-Sinai

When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.

Released: 12-Aug-2022 1:05 PM EDT
Smart contact lenses for cancer diagnostics and screening
Terasaki Institute for Biomedical Innovation

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a contact lens that can capture and detect exosomes, nanometer-sized vesicles found in bodily secretions which have the potential for being diagnostic cancer biomarkers.

Released: 12-Aug-2022 1:00 PM EDT
AI algorithm that detects brain abnormalities could help cure epilepsy
University College London

An artificial intelligence (AI) algorithm that can detect subtle brain abnormalities which cause epileptic seizures has been developed by a UCL-led team of international researchers.

Newswise: Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions
12-Aug-2022 12:00 PM EDT
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions
University of Texas M. D. Anderson Cancer Center

The targeted therapy pralsetinib was well-tolerated and demonstrated high response rates in patients with RET gene fusions regardless of tumor type, according to results from the Phase I/II ARROW trial.

Newswise: Support Yourself and Others while Experiencing Grief during the Cancer Journey
Released: 12-Aug-2022 11:45 AM EDT
Support Yourself and Others while Experiencing Grief during the Cancer Journey
Rutgers Cancer Institute of New Jersey

Social Worker at Rutgers Cancer Institute of New Jersey shares tips for both patients and caregivers on managing grief during the cancer journey.

Released: 12-Aug-2022 11:05 AM EDT
More than 1 in 4 children hospitalized with COVID-19 or MIS-C have lingering complications more than two months later
Boston Children's Hospital

In one of the largest follow-up studies to date, involving 25 pediatric hospitals, more than a quarter of children and adolescents hospitalized with coronavirus infection early in the pandemic still had health problems two to four months later, either persisting symptoms or activity impairment.

Newswise: Safer imaging technology for complex aortic repairs uses light instead of X-rays
Released: 12-Aug-2022 11:05 AM EDT
Safer imaging technology for complex aortic repairs uses light instead of X-rays
UT Southwestern Medical Center

A new imaging device at UT Southwestern is making complex aortic repairs safer for patients and operating room staff by dramatically reducing their exposure to radiation. The device, known as Fiber Optic RealShape (FORS) and manufactured by Philips, uses light to visualize blood vessels, nearly eliminating the need for X-rays typically used during minimally invasive vascular procedures.

11-Aug-2022 10:55 AM EDT
Nationwide study shows rise in pregnancy-related complications during COVID-19 pandemic
Beth Israel Deaconess Medical Center

In a paper published in JAMA Network Open, physician-scientists assessed how pregnancy-related complications and obstetric outcomes changed during the COVID-19 pandemic compared to pre-pandemic.

Newswise: Two Monumental Milestones Achieved in CT Imaging
Released: 12-Aug-2022 10:05 AM EDT
Two Monumental Milestones Achieved in CT Imaging
National Institute of Biomedical Imaging and Bioengineering

Two biomedical imaging technologies developed with support from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have been cleared for clinical use by the Food and Drug Administration (FDA). Both technologies offer advances in computed tomography (CT).

   
Released: 12-Aug-2022 10:05 AM EDT
Explore a New Development in Studying Cell Motility and More in the August Issue of SLAS Technology – Available Now
SLAS

The August issue of SLAS Technology is now available Open Access on ScienceDirect.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 17-Aug-2022 5:00 PM EDT Released to reporters: 12-Aug-2022 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Aug-2022 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Neurosurgeon Ashish Shah Returns to Sylvester to Head Clinical Trials and Translational Research on Brain Tumors
Released: 12-Aug-2022 10:05 AM EDT
Neurosurgeon Ashish Shah Returns to Sylvester to Head Clinical Trials and Translational Research on Brain Tumors
Sylvester Comprehensive Cancer Center

Ashish Shah, M.D., has assumed the newly created position of director of clinical trials and translational research and principal investigator in the Section of Virology and Immunotherapy at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative (BTI) at the University of Miami Miller School of Medicine. Dr. Shah, who calls himself a “quadruple ’Cane,” returns to the site of his undergraduate studies, medical school, and residency as a faculty member. This follows a year-long fellowship at the National Institutes of Health, where he focused on clinical trial design and translational neuro-oncology.

access_time Embargo lifts in 2 days
This news release is embargoed until 19-Aug-2022 10:00 AM EDT Released to reporters: 12-Aug-2022 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Aug-2022 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center
Released: 12-Aug-2022 9:50 AM EDT
Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center
Mount Sinai Health System

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

Newswise: KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
Released: 12-Aug-2022 9:30 AM EDT
KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
University of Kansas Cancer Center

Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.

Released: 12-Aug-2022 8:05 AM EDT
Betamethasone could improve outcomes for prostate cancer radiation therapy
University of Kentucky

A new study published by University of Kentucky Markey Cancer Center researchers suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.

Newswise: Breast cancer cells use forces to open up channels through tissue
Released: 12-Aug-2022 1:05 AM EDT
Breast cancer cells use forces to open up channels through tissue
Aalto University

New method uses nanospheres to measure forces that cancer cells use to spread through tissue

   
Released: 11-Aug-2022 5:35 PM EDT
Powerful new antibody neutralizes all known SARS-CoV-2 variants
Boston Children's Hospital

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially Omicron, have developed ways to evade the antibodies we make in response to vaccines.

Newswise: TTU System Board of Regents Approves Appointments of Grover E. Murray Professors
Released: 11-Aug-2022 5:05 PM EDT
TTU System Board of Regents Approves Appointments of Grover E. Murray Professors
Texas Tech University Health Sciences Center

The Texas Tech University System Board of Regents approved the appointments of Texas Tech University Health Sciences Center faculty Sherry Sancibrian and Thomas Hale, Ph.D., R.Ph., as Grover E. Murray Professors.

Released: 11-Aug-2022 5:05 PM EDT
Creating an 'adult-like' mature human cardiac tissue
University of Connecticut

Researchers in the Biomedical Engineering Department at UConn have developed a new cardiac cell-derived platform that closely mimics the human heart, unlocking potential for more thorough preclinical drug development and testing, and model for cardiac diseases.

Newswise: Ochsner and Tulane collaboration uncovers what happens to genes inside artery plaques to trigger strokes
Released: 11-Aug-2022 4:40 PM EDT
Ochsner and Tulane collaboration uncovers what happens to genes inside artery plaques to trigger strokes
Ochsner Health

Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke. The work, published in Scientific Reports, was made possible by acquiring samples closer to the time of the stroke than previously possible. The results provide a picture of what the cells in the plaque are doing near the moment they induce a stroke.

Released: 11-Aug-2022 4:20 PM EDT
Veterans are reluctant to seek help for sleep problems or substance use
University of Missouri, Columbia

American military veterans are least willing to seek treatment for the health conditions that are most prevalent in their communities — including sleep and alcohol use problems — according to a new study from the University of Missouri School of Medicine.

Released: 11-Aug-2022 4:10 PM EDT
Health inequalities among ethnic groups have increased since pandemic, evidence shows
University of Leicester

Existing health disparities amongst ethnic minorities with diabetes have worsened during the COVID-19 pandemic, a new study published in the journal Diabetes Care has reported.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Aug-2022 4:00 PM EDT Released to reporters: 11-Aug-2022 4:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Aug-2022 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Leaving small kidney stones behind causes problems later
Released: 11-Aug-2022 4:05 PM EDT
Leaving small kidney stones behind causes problems later
University of Washington School of Medicine

A new randomized controlled study showed, however, that leaving these asymptomatic stones behind significantly increases the risk of a patient's relapse in the following five years. The findings were published today in the New England Journal of Medicine.

Released: 11-Aug-2022 4:05 PM EDT
Why thinking hard makes you tired
Cell Press

It’s no surprise that hard physical labor wears you out, but what about hard mental labor?

access_time Embargo lifts in 2 days
This news release is embargoed until 15-Aug-2022 7:00 AM EDT Released to reporters: 11-Aug-2022 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Aug-2022 7:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Aug-2022 3:05 PM EDT
Portable cancer testing expands in sub-Saharan Africa
Cornell University

A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine has been deployed in clinical tests in Uganda to identify cases of Kaposi sarcoma, a common yet difficult-to-detect cancer that often signals the presence of HIV infection.

   
Released: 11-Aug-2022 2:45 PM EDT
Large number of stem cell lines carry significant DNA damage, say researchers
University of Cambridge

DNA damage caused by factors such as ultraviolet radiation affect nearly three-quarters of all stem cell lines derived from human skin cells, say Cambridge researchers, who argue that whole genome sequencing is essential for confirming if cell lines are usable.

Released: 11-Aug-2022 2:25 PM EDT
KidneyX Launches New Artificial Kidney Prize with $10.5 Million in Funding
American Society of Nephrology (ASN)

Today, the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced a new prize competition from the Kidney Innovation Accelerator (KidneyX) that seeks to further the development of a fully functional bioartificial kidney.

Newswise: Bioengineered cornea can restore sight to the blind and visually impaired
Released: 11-Aug-2022 2:10 PM EDT
Bioengineered cornea can restore sight to the blind and visually impaired
Linkoping University

Researchers and entrepreneurs have developed an implant made of collagen protein from pig’s skin, which resembles the human cornea.

Newswise:Video Embedded second-opinions-and-a-heroic-mother-lead-to-second-chances-at-life
VIDEO
Released: 11-Aug-2022 2:05 PM EDT
Second Opinions and a Heroic Mother Lead to Second Chances at Life
Cedars-Sinai

Adelynn Garza knows a thing or two about beating the odds.

Newswise: Simplified Voice Box Enriches Human Speech
Released: 11-Aug-2022 2:00 PM EDT
Simplified Voice Box Enriches Human Speech
Kyoto University

The evolution of the human larynx contributed to the stable voices we use to communicate. The morphological changes do not include the addition of structures but rather the loss of specific vocal folds or cords in the larynx, providing a stable voice quality and controllable voice pitch used when singing or speaking.

   
5-Aug-2022 2:35 PM EDT
New antibiotic resistance genes identified in tuberculosis
PLOS

An international consortium analyzed the genetic sequences and antibiotic susceptibility of more than 10,000 global Mycobacterium tuberculosis isolates.

Released: 11-Aug-2022 1:55 PM EDT
How Not to Use Brain Scans in Neuroscience
University of Pittsburgh

The idea that a lone snapshot of a brain can tell you about an individual’s personality or mental health has been the basis of decades of neuroscience studies. That approach was punctured by a paper in Nature earlier this year showing that scientists have massively underestimated how large such studies must be to produce reliable findings. At the center of the research is MRI (magnetic resonance imaging) brain scans. Reaching that conclusion required getting a far broader view of the field than was possible until recently. Along with colleagues at a number of institutions as well as his advisor, Pitt Professor of Psychiatry Beatriz Luna, Tervo-Clemmens combined three recent publicly available studies that together included MRI data from around 50,000 participants.

Released: 11-Aug-2022 1:05 PM EDT
COVID-19 genomic recombination is uncommon but disproportionately occurs in spike protein region
University of California, Santa Cruz

An analysis of millions of SARS-CoV-2 genomes finds that recombination of the virus is uncommon, but when it occurs, it is most often in the spike protein region, the area which allows the virus to attach to and infect host cells.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 16-Aug-2022 5:00 PM EDT Released to reporters: 11-Aug-2022 12:55 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Aug-2022 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

150 of 141370

close
2.00344